Fulgent Genetics (NASDAQ:FLGT – Get Free Report) and Agilon Health (NYSE:AGL – Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, earnings, risk and valuation.
Earnings & Valuation
This table compares Fulgent Genetics and Agilon Health”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Fulgent Genetics | $322.67 million | 1.82 | -$60.51 million | ($2.82) | -7.57 |
| Agilon Health | $5.92 billion | 0.25 | -$391.35 million | ($14.27) | -6.17 |
Fulgent Genetics has higher earnings, but lower revenue than Agilon Health. Fulgent Genetics is trading at a lower price-to-earnings ratio than Agilon Health, indicating that it is currently the more affordable of the two stocks.
Institutional & Insider Ownership
48.1% of Fulgent Genetics shares are held by institutional investors. 36.2% of Fulgent Genetics shares are held by insiders. Comparatively, 2.5% of Agilon Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Profitability
This table compares Fulgent Genetics and Agilon Health’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Fulgent Genetics | -26.05% | -4.93% | -4.50% |
| Agilon Health | -3.92% | -119.38% | -16.85% |
Analyst Recommendations
This is a breakdown of current ratings and recommmendations for Fulgent Genetics and Agilon Health, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Fulgent Genetics | 1 | 2 | 1 | 0 | 2.00 |
| Agilon Health | 2 | 7 | 6 | 0 | 2.27 |
Fulgent Genetics presently has a consensus price target of $27.50, suggesting a potential upside of 28.87%. Agilon Health has a consensus price target of $102.25, suggesting a potential upside of 16.08%. Given Fulgent Genetics’ higher possible upside, equities research analysts plainly believe Fulgent Genetics is more favorable than Agilon Health.
Risk & Volatility
Fulgent Genetics has a beta of 0.93, meaning that its share price is 7% less volatile than the S&P 500. Comparatively, Agilon Health has a beta of 2.98, meaning that its share price is 198% more volatile than the S&P 500.
Summary
Fulgent Genetics beats Agilon Health on 8 of the 14 factors compared between the two stocks.
About Fulgent Genetics
Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company’s clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California.
About Agilon Health
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.
Receive News & Ratings for Fulgent Genetics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fulgent Genetics and related companies with MarketBeat.com's FREE daily email newsletter.
